Association for accessible medicines

Biosimilar medicines

Biosimilar medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least 31% lower than the original price of the branded medicine. Biosimilars are essential to making expensive biologic treatments available as widely as possible.
Read more

Generic medicines

Generic medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least between 54% and 60% lower than the original price of the branded medicine. Generic medicines allow more patients to be better treated.
Read more

Self-care products

Self-care products are products that are freely available at pharmacies, such as self-care medicines, self-care medical devices and food supplements. Patients can use them upon their own initiative, to preserve their health. Their ‘good use’ substantially reduces the social costs of being ill.
Read more

News

14/02

Medicines for Europe & Medaxes urge the EU institutions to adopt the SPC manufacturing waiver

Medicines for Europe and Medaxes urge the EU institutions to adopt the SPC manufacturing waiver for patients, sustainable healthcare and manufacturing jobs

04/02

European Falsified Medicines Directive (FMD) goes live 9 February

Video on the origins and application of this European Directive to combat the entry of falsified medicines into the legal supply chain. Also the Medaxes members fully support this Directive.

            Video about Medaxes

/sites/default/files/styles/banner/public/2018-10/caleb-jones-135058.jpg?h=28fdc21a&itok=wU_tyZE5

Our members